Report copyright - Patient Preferences for GLP-1 Receptor Agonist Treatment of … · 2019. 3. 27. · CV outcomes trial, which evaluated dulaglutide 1.5 mg as an add-on to the standard-of-care treatment
Please pass captcha verification before submit form